Literature DB >> 33790473

FDA approves first BCMA-targeted CAR-T cell therapy.

Asher Mullard.   

Abstract

Entities:  

Year:  2021        PMID： 33790473     DOI： 10.1038/d41573-021-00063-1

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  17 in total

1.  T cells isolated from G-CSF-treated multiple myeloma patients are suitable for the generation of BCMA-directed CAR-T cells.

Authors:  Anthony M Battram; Aina Oliver-Caldés; Maria Suárez-Lledó; Miquel Lozano; Miquel Bosch I Crespo; Núria Martínez-Cibrián; Joan Cid; David F Moreno; Luis Gerardo Rodríguez-Lobato; Alvaro Urbano-Ispizua; Carlos Fernández de Larrea
Journal:  Mol Ther Methods Clin Dev       Date:  2022-06-22       Impact factor: 5.849

2.  Spermidine Promotes Nb CAR-T Mediated Cytotoxicity to Lymphoma Cells Through Elevating Proliferation and Memory.

Authors:  Hongxia Wang; Dan Jiang; Liyuan Liu; Yanting Zhang; Miao Qin; Yuliang Qu; Liyan Wang; Shan Wu; Haijin Zhou; Tao Xu; Guangxian Xu
Journal:  Onco Targets Ther       Date:  2022-10-18       Impact factor: 4.345

Review 3.  Strategies for Manipulating T Cells in Cancer Immunotherapy.

Authors:  Hyang-Mi Lee
Journal:  Biomol Ther (Seoul)       Date:  2022-03-10       Impact factor: 4.231

4.  IL-27 improves adoptive CD8+ T cells' antitumor activity via enhancing cell survival and memory T cell differentiation.

Authors:  Miao Ding; Yi Fei; Jianmin Zhu; Ji Ma; Guoqing Zhu; Ni Zhen; Jiabei Zhu; Siwei Mao; Fenyong Sun; Feng Wang; Qiuhui Pan
Journal:  Cancer Sci       Date:  2022-05-18       Impact factor: 6.518

5.  Novel BCMA-OR-CD38 tandem-dual chimeric antigen receptor T cells robustly control multiple myeloma.

Authors:  Yaru Feng; Xiuying Liu; Xiaorui Li; Yating Zhou; Zhiru Song; Jing Zhang; Bingjie Shi; Jianxun Wang
Journal:  Oncoimmunology       Date:  2021-08-17       Impact factor: 8.110

6.  Humanized Chimeric Antigen Receptor (CAR) T cells.

Authors:  Pouya Safarzadeh Kozani; Pooria Safarzadeh Kozani; Roddy S O'Connor
Journal:  J Cancer Immunol (Wilmington)       Date:  2021

Review 7.  Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward.

Authors:  Pouya Safarzadeh Kozani; Pooria Safarzadeh Kozani; Fatemeh Rahbarizadeh
Journal:  Front Immunol       Date:  2021-10-28       Impact factor: 7.561

Review 8.  Molecular Immune Targeted Imaging of Tumor Microenvironment.

Authors:  Taha Rakhshandehroo; Bryan Ronain Smith; Hannah J Glockner; Mohammad Rashidian; Neeta Pandit-Taskar
Journal:  Nanotheranostics       Date:  2022-02-15

Review 9.  Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy.

Authors:  Laetitia Vercellino; Dorine de Jong; Roberta di Blasi; Salim Kanoun; Ran Reshef; Lawrence H Schwartz; Laurent Dercle
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

Review 10.  Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer.

Authors:  Violet Y Tu; Asma Ayari; Roddy S O'Connor
Journal:  Antibodies (Basel)       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.